Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
Quick Stats
Apr 02, 202662.7
AI Score
BUY0.29
Volume Ratio
May 11, 2026
Next Earnings
14
+ve Days (30d)
15
-ve Days (30d)
AUPH Stock Summary
Last updated Apr 02, 2026
AUPH is currently trading at $15.175, positioned above its 200-day moving average of $13.01, indicating a long-term uptrend. The stock has a 52-week range of $6.825 to $16.54.
Technical Analysis: The 50-day moving average stands at $14.5, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 59.039, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is 0.108, which is positive, indicating accumulation by institutional investors. Our AI-powered investment score rates AUPH at 62.7/100 with a BUY recommendation.
AUPH (Aurinia Pharmaceuticals Inc) Indicators
Last updated Apr 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 59.039 |
| CMF (20) | 0.108 |
| ROC (10) | 8.742 |
| ADX (14) | 13.704 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.106 |
| AROONOSC (14) | 14.286 |
| WILLAMS %R (14) | -16.338 |
| MFI (14) | 49.36 |
AUPH Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
AUPH Price vs Max Options Open Interest
AUPH Max Change In Options Open Interest
AUPH Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AUPH Daily Out of Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AUPH Daily In the Money Options - Sort by Max open Interest (near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
AUPH Most Active Options by Volume(near term)
2nd April 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Aurinia Pharmaceuticals Inc is above both 50 Day and 200 Day SMA which is considered Bullish.
AUPH Moving Averages Analysis
Aurinia Pharmaceuticals Inc has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Apr 02, 2026
Aurinia Pharmaceuticals Inc has been above 200 day sma 1 times in last 30 days. Last time it was above 200 day sma was on Apr 02, 2026
AUPH (Aurinia Pharmaceuticals Inc) Simple Moving Averages
Moving Averages are last updated Apr 02, 2026
| Days | MA |
|---|---|
| 10 | 14.55 |
| 20 | 14.45 |
| 30 | 14.45 |
| 50 | 14.5 |
| 100 | 15.04 |
| 200 | 13.01 |
AUPH Fundamental Analysis
| P/E (Forward) | 17.301 |
| P/E (Trailing) | 7.1594 |
| Market Cap ($) | 2.0 billion |
| Earnings/Share ($) | 2.07 |
| Net Proft Margin (%) | 1.0147 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.835 |
| EPS Estimate Next Year ($) | 0.835 |
| WallStreet Target Price ($) | 17 |
| Most Recent Quarter |